• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

Crowdfunding Effort Targets Patients Seeking Genome Sequencing

by Jasmine Pennic 06/19/2015 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Crowdfunding Effort Targets Patients Seeking Genome Sequencing

Rare Genomics Institute (RG) is launching a 30-day crowdfunding bootcamp to help rare disease patients raise funds for high-end exome sequencing to pinpoint the cause of their disease and map possible treatments.  The training session is an integral part of Amplify Hope, a new RG program that navigates patients and their families through the emerging fundraising opportunities. The project, funded by the Templeton Foundation, is free for the participants.

By providing an expert network and an online crowdfunding mechanism Rare Genomics works alongside patients and their families, providing them with the necessary tools, knowledge, and connections so that they can better understand the cause of their disease. The 30-day bootcamp will train families how to understand available fundraising platforms, plot campaigns,  and leverage social media more effectively with eye-catching images and videos. Top fundraising experts will also be conducting free webinars and offering remote support to showcase most effective email templates and messaging strategies.

“Rare Genomics Institute has helped many affected families by putting them in touch with the World’s top rare disease and genomics specialists,” said Jimmy Lin, MD, PhD, MHS, President of the Rare Genomics Institute. “However, expert opinion is sometimes not enough: proper diagnosis requires sophisticated genome sequencing and other research, often on the brink of human knowledge. The reality is that such projects are very costly. That is why, in addition to global scientific expertise, we will be involving top fundraising experts and provide hands-on coaching that was not possible before. I am excited to see how the Amplify Hope Initiative will help families raise much-needed funds to uncover the cause of their child’s illness.”

Scientific partners on this project include two life sciences technology leaders: Ambry Genetics and Baylor Miraca Genetics Laboratories. Crowdfunding partners include three leading industry pioneers:

– CrowdRise

– Indiegogo Life

– YouCaring

Communications software for the project is provided by xTeros.

For more information about the Amplify Hope Initiative and to apply, please visithttp://amplifyhope.raregenomics.org/ 

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

2026 Predictions & Trends

Healthcare 2026 Forecast: Executives on AI Survival, Financial Reckoning, and the End of Point Solutions

2026 Healthcare Executive Predictions: Why the AI “Pilot Era” Is Officially Over

Featured Research Report

Digital Health Funding Hits $14.2B in 2025: A Year of AI Exuberance and Market Bifurcation

Most-Read

Trump Unveils 'The Great Healthcare Plan': A Global Price-Matching Pivot to Settle the Affordability Crisis

Price Reset 2026: How Trump’s ‘Great Healthcare Plan’ Slashes Drug Costs at Trumprx.gov

Anthropic Debuts ‘Claude for Healthcare’ and Opus 4.5 to Engineer the Future of Life Sciences

Anthropic Debuts ‘Claude for Healthcare’ and Opus 4.5 to Engineer the Future of Life Sciences

OpenAI Debuts ChatGPT Health: A ‘Digital Front Door’ That Connects Medical Records to Agentic AI

OpenAI Debuts ChatGPT Health: A ‘Digital Front Door’ That Connects Medical Records to Agentic AI

From Genes to Hackers: The Hidden Cybersecurity Risks in Life Sciences

From Genes to Hackers: The Hidden Cybersecurity Risks in Life Sciences

Utah Becomes First State to Approve AI System for Prescription Renewals

Utah Becomes First State to Approve AI System for Prescription Renewals

NYC Health + Hospitals to Acquire Maimonides in $2.2B Safety Net Overhaul

NYC Health + Hospitals to Acquire Maimonides in $2.2B Safety Net Overhaul

KLAS Report: Why Hospitals Are Choosing Efficiency Over 'Agentic' AI Hype in 2025

KLAS Report: Why Hospitals Are Choosing Efficiency Over ‘Agentic’ AI Hype in 2025

Advanced Primary Care 2026: Top 6 Investments for Health Systems According to Harvard Medical School

Advanced Primary Care 2026: Top 6 Investments for Health Systems According to Harvard Medical School

AI Nutrition Labels: The Key to Provider Adoption and Patient Trust?

AI Nutrition Labels: The Key to Provider Adoption and Patient Trust?

Kristen Hartsell, VP of Clinical Services, RedSail Technologies

The Pharmacy Closures Crisis: How Independent Pharmacies Are Fixing Pharmacy Deserts

Secondary Sidebar

Footer

Company

  • About Us
  • 2026 Editorial Calendar
  • Advertise with Us
  • Reprints and Permissions
  • Op-Ed Submission Guidelines
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2026. HIT Consultant Media. All Rights Reserved. Privacy Policy |